Navigation Links
Rush-Copley Medical Center Selects Pharmacy Xpert from Thomson Reuters to Improve Medication Management
Date:12/7/2010

ANN ARBOR, Mich., Dec. 7, 2010 /PRNewswire/ -- Thomson Reuters today announced Rush-Copley Medical Center has selected Thomson Reuters Pharmacy Xpert to more effectively manage medication therapy and improve pharmacist efficiency.  Pharmacy Xpert is a one-of-a-kind clinical intelligence dashboard that helps hospital pharmacists better manage medication therapy to improve outcomes, reduce costs, and manage risk.

"Pharmacy Xpert will take data from multiple sources from around our hospital and deliver it to one convenient dashboard, allowing our pharmacists to be more efficient and more effective in managing medication therapy," said Nancy Donner, PharmD, director of pharmacy services at Rush-Copley Medical Center. "We look forward to putting it in practice to improve pharmacy workflow, reduce our medication costs, and minimize medication errors."

Pharmacy Xpert combines three critical elements – real-time clinical surveillance, comprehensive patient data, and patient-specific Micromedex reference content – into a single dashboard.  

The real-time surveillance capability uses clinical profiles to automatically identify patients who are at risk of an adverse event, such as a potentially lethal combination or dosage of medications. It also helps pharmacists save thousands of dollars in medication costs by identifying alternative, yet equally effective, medication therapies – such as a lower-cost oral medication in place of a drug administered intravenously.  Once the at-risk patients are identified the pharmacist then has access to all the clinical data they need to make the appropriate medication recommendation.

Pharmacy Xpert is part of the Clinical Xpert™ suite of clinical workflow solutions. It can be quickly integrated within any hospital IT environment — including hospitals using platforms from Cerner, Eclipsys, Epic, GE, MEDITECH, McKesson and Siemens.

'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
2. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
3. ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
4. Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
5. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
6. BioMS Medical Announces Second Quarter 2008 Results
7. ATS Medical to Participate at the Fourth Annual Noble Financial Equity Conference
8. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
9. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
10. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
11. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 iLuv Creative Technology, the ... for the mobile lifestyle, announces they are now shipping ... manage multiple iPad devices efficiently. Winner of the 2013 ... Good Design award, MultiCharger-X is revolutionizing the way businesses, ... is deployed. , MultiCharger-X (iAD910) combines ...
(Date:5/22/2013)... 22, 2013  Empire Genomics announced today it ... pending novel genomic biomarker from Cornell University for ... could help in diagnosing and determining treatment for ... Neuroendocrine prostate cancer (NEPC) is a lethal ... de novo, but more commonly arises after hormonal ...
(Date:5/22/2013)...  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the ... LLP Microcap Conference, May 30, in New York, ... , CPA, Chief Financial Officer of Cleveland BioLabs, will ... at 1:30 p.m. Eastern Time.  A live and archived webcast ... page of the Cleveland BioLabs website at www.cbiolabs.com . ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Alton Housing Authority ... May 15, 2013 said that their presence has already ... bed bug sufferers avoid such big spending, My Cleaning Products ... inexpensively. , It was said in the report that to ... MCP related. Apart from that, its employees also attended a ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2
... It's been a long campaign season, and you've been poked ... national press corps member. John Kerry drank a beer at ... at your local kindergarten. Dick Cheney was spotted more in ... in the last four years. John Edwards has been in ...
... drug purification products Business filings serves ... dip in third-quarter earnings from mild weather ... Wisconsin-based Analogix joins French company to ... maker of drug-purification devices based in Burlington, Wisconsin, has ...
... more hours in the day so I can get more done (like ... We "fall back" into standard time and get another hour. But what ... my desk, which I always promise to do when I have more ... wanted to share in this column. Here they are, in no particular ...
Cached Biology Technology:Twenty ways you can tell this campaign has finally pushed you over the edge 2Tech Digest: whats moving in the Midwest (11/1/04) 2Music, mail, databases and printing from a technologists desk 2Music, mail, databases and printing from a technologists desk 3
(Date:5/21/2013)... The largest gathering of biomass experts , ... , When? 03-07 June 2013 ... scientific research, resource assessment, market and policy developments, manufacturing ... the world and benefiting from its 2013 edition from ... more than 60 countries, more than 240 plenary and ...
(Date:5/21/2013)... May 21, 2013 Royal Philips Electronics (NYSE: ... world,s first portable ultrasound with Philips, industry leading Live ... The CX50 xMATRIX with available Live 3D TEE and ... at the EuroPCR, official meeting for the European ... Since its launch in 2012, Philips CX50 xMATRIX ...
(Date:5/20/2013)... antibiotic colistin are also commonly resistant to antimicrobial ... a study in mBio , the online ... Cross-resistance to colistin and host antimicrobials LL-37 and ... attack, could mean that patients with life-threatening multi-drug ... immune response. Colistin is a last-line drug for ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... Alabama used worms to reel in information that they hope ... may be exploited to treat epilepsy. In a new research ... the researchers explain how the transparent roundworm, C. elegans ... transport of a molecule (gamma-aminobutyric acid or "GABA") that if ...
... b3c newswire / - Critical Outcome Technologies ... from animal experiments carried out at a prominent Canadian ... to the already impressive data package for COTI-2, demonstrating ... first line therapies with low toxicity in seven different ...
... the primary cause of cancer mortality in children. Even ... tremendously from the stressful treatment which can be harmful ... need for target-oriented, gentle treatment methods. The most important ... approximately one hundred young patients each year in Germany, ...
Cached Biology News:More than fish bait: Worms unlock secrets to new epilepsy treatments 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Biology Products: